Slater S D, Williamson R C, Foster C S
Department of Histopathology, Royal Postgraduate Medical School, Hammersmith Hospital, London, U.K.
J Pathol. 1998 Sep;186(1):104-8. doi: 10.1002/(SICI)1096-9896(199809)186:1<104::AID-PATH141>3.0.CO;2-#.
This study was performed to determine whether pancreatic parenchymal epithelial cells in human chronic pancreatitis tissues retain a biologically significant capability to proliferate and, if so, within which epithelial compartment proliferation occurs. The techniques of immediate per-operative in vitro labelling with bromodeoxyuridine (BrdU) and conventional immunohistochemistry for Ki-67 antigen expression were used to identify proliferating cells. Concordance between the two techniques was confirmed in all tissues examined. In normal pancreas, proliferation was restricted to acinar epithelial cells, with no activity in the ductules. In chronic pancreatitis of both chronic obstructive and chronic calcifying types, the number of proliferating cells in the acini was significantly increased. A small population of proliferating cells was also apparent within ductules in chronic calcifying pancreatitis, but not in chronic obstructive pancreatitis. This investigation has shown that loss of parenchymal epithelium occurring in chronic pancreatitis is not caused by a primary failure of pancreatic 'stem-cell' proliferation, but is due to disproportionate attrition of differentiated parenchymal epithelial cells by a mechanism, possibly stromal in origin, which remains hitherto unidentified. The presence of proliferating ductular cells in chronic calcifying pancreatitis, but not chronic obstructive pancreatitis, suggests that distinct pathogenic processes may be operating in the former condition, which is classically regarded as secondary to ductal obstruction by stones, and in this single respect might be considered to be identical to chronic obstructive pancreatitis. Preservation of 'stem-cell' function supports the belief that regeneration of pancreatic parenchymal tissue could be a feasible proposition if biologically appropriate management strategies were developed to treat chronic calcifying pancreatitis.
本研究旨在确定人类慢性胰腺炎组织中的胰腺实质上皮细胞是否保留具有生物学意义的增殖能力,若有,则确定增殖发生在哪个上皮区室。采用溴脱氧尿苷(BrdU)术中即时体外标记技术和检测Ki-67抗原表达的传统免疫组织化学方法来识别增殖细胞。在所有检测的组织中均证实了这两种技术结果的一致性。在正常胰腺中,增殖仅限于腺泡上皮细胞,小导管无增殖活性。在慢性阻塞性和慢性钙化性慢性胰腺炎中,腺泡中增殖细胞的数量均显著增加。在慢性钙化性胰腺炎的小导管内也可见少量增殖细胞,但慢性阻塞性胰腺炎中未见。本研究表明,慢性胰腺炎中实质上皮的缺失并非由胰腺“干细胞”增殖的原发性失败所致,而是由于分化的实质上皮细胞因一种可能起源于基质但迄今尚未明确的机制而过度损耗。慢性钙化性胰腺炎而非慢性阻塞性胰腺炎中存在增殖的小导管细胞,提示在前一种通常被认为继发于结石导致的导管阻塞的疾病中可能存在不同的致病过程,仅在这一点上可认为与慢性阻塞性胰腺炎相同。“干细胞”功能的保留支持这样一种观点,即如果能制定出生物学上合适的管理策略来治疗慢性钙化性胰腺炎,胰腺实质组织的再生可能是可行的。